Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice

Cited 39 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorS H Jeong-
dc.contributor.authorM N Kim-
dc.contributor.authorM Y Han-
dc.contributor.authorH H Lee-
dc.contributor.authorJ W Ahn-
dc.contributor.authorM Z Kim-
dc.contributor.authorY H Song-
dc.contributor.authorC O Shin-
dc.contributor.authorKi Hoan Nam-
dc.contributor.authorT W Kim-
dc.contributor.authorG T Oh-
dc.contributor.authorM C Yoon-
dc.date.accessioned2017-04-19T09:01:13Z-
dc.date.available2017-04-19T09:01:13Z-
dc.date.issued2004-
dc.identifier.issn0026-0495-
dc.identifier.uri10.1016/j.metabol.2003.12.010ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/6537-
dc.description.abstractOur previous study demonstrated that fenofibrate improves both lipid metabolism and obesity, in part through hepatic peroxisome proliferator-activated receptor α (PPARα) activation, in female ovariectomized, but not in sham-operated, low-density lipoprotein receptor-null (LDLR-null) mice. The aim of this study was to determine whether fenofibrate prevents obesity and hypertriglyceridemia in male LDLR-null mice. Mice fed a high-fat diet for 8 weeks exhibited increases in body and white adipose tissue (WAT) weights and developed severe hypertriglyceridemia compared with mice fed a low-fat control diet. However, these effects were effectively prevented by fenofibrate. Mice given a fenofibrate-supplemented high-fat diet showed significantly reduced body weight, WAT weight, and serum triglycerides versus high-fat diet-fed animals. Triton WR1339 study showed that fenofibrate-induced reduction in circulating triglycerides was due to the decreased secretion of triglycerides from the liver. Moreover, the administration of fenofibrate not only resulted in liver hypertrophy and reduction in hepatic lipid accumulation, but also regulated the transcriptional expression of PPARα target genes, such as hepatic acyl-coenzyme A (CoA) oxidase and apolipoprotein C-III (apoC-III). Therefore, our results suggest that alterations in hepatic PPARα action by fenofibrate seem to suppress diet-induced obesity and severe hypertriglyceridemia caused by LDLR deficiency in male mice.-
dc.publisherElsevier-
dc.titleFenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice-
dc.title.alternativeFenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice-
dc.typeArticle-
dc.citation.titleMetabolism-Clinical and Experimental-
dc.citation.number5-
dc.citation.endPage613-
dc.citation.startPage607-
dc.citation.volume53-
dc.contributor.affiliatedAuthorKi Hoan Nam-
dc.contributor.alternativeName정선효-
dc.contributor.alternativeName김미나-
dc.contributor.alternativeName한미영-
dc.contributor.alternativeName이형희-
dc.contributor.alternativeName안지원-
dc.contributor.alternativeName김문자-
dc.contributor.alternativeName송양헌-
dc.contributor.alternativeName신추옥-
dc.contributor.alternativeName남기환-
dc.contributor.alternativeName김태우-
dc.contributor.alternativeName오구택-
dc.contributor.alternativeName윤미정-
dc.identifier.bibliographicCitationMetabolism-Clinical and Experimental, vol. 53, no. 5, pp. 607-613-
dc.identifier.doi10.1016/j.metabol.2003.12.010-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.